Details for New Drug Application (NDA): 012359
✉ Email this page to a colleague
NDA 012359 describes SALUTENSIN-DEMI, which is a drug marketed by Shire and is included in one NDA. Additional details are available on the SALUTENSIN-DEMI profile page.
The generic ingredient in SALUTENSIN-DEMI is hydroflumethiazide; reserpine. There are two drug master file entries for this compound. Additional details are available on the hydroflumethiazide; reserpine profile page.
The generic ingredient in SALUTENSIN-DEMI is hydroflumethiazide; reserpine. There are two drug master file entries for this compound. Additional details are available on the hydroflumethiazide; reserpine profile page.
Summary for 012359
| Tradename: | SALUTENSIN-DEMI |
| Applicant: | Shire |
| Ingredient: | hydroflumethiazide; reserpine |
| Patents: | 0 |
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 50MG;0.125MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 004
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 25MG;0.125MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
